SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) — VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized with a blue ribbon “Poster…Read More

You might also be interested in reading Ripple Labs Is ‘Interested’ in Bankrupt Crypto Lender Celsius and Its Assets, Company Spokesperson Says.